甲状腺髓样癌的早期诊断:在高敏降钙素免疫分析时代,降钙素刺激试验是否仍有指征?
该研究连续纳入149例甲状腺结节且基础降钙素升高的患者,均行手术及系统淋巴结清扫,比较基础降钙素与钙刺激后降钙素对甲状腺髓样癌及侧颈淋巴结转移的诊断效能;结果显示基础降钙素诊断效能更优,联合检测未提高准确性,性别特异性基础降钙素阈值有助于早期诊断和预测侧颈淋巴结转移。
要点
- 基础降钙素诊断甲状腺髓样癌的AUC在男性为0.894、女性为0.935,均优于钙刺激后降钙素。
- 钙刺激后降钙素未改善术前诊断,联合检测未提高诊断准确性。
- 女性基础降钙素>85 pg/mL、男性>100 pg/mL预测侧颈淋巴结转移的敏感性为100%。
核心结论
- 预设的性别特异性基础降钙素阈值有助于甲状腺髓样癌的早期检测和侧颈淋巴结转移的预测。
- 钙刺激后降钙素未改善术前诊断,联合检测未提高诊断准确性。
- 男性基础降钙素>43和>100 pg/mL、女性>23和>85 pg/mL对患者咨询和手术范围规划有参考价值。
研究设计与样本
- 对149例连续纳入的甲状腺结节且基础降钙素升高的患者行钙刺激试验。
- 无论钙刺激后降钙素水平如何,所有患者均按统一手术方案行甲状腺切除术和系统淋巴结清扫。
- 采用新近发表的性别特异性 cutoff 值区分甲状腺髓样癌与其他C细胞病变(C细胞增生),用ROC分析比较基础降钙素或钙刺激后降钙素单独及联合的诊断效能。
- 评估基础降钙素与钙刺激后降钙素预测侧颈淋巴结转移的cutoff值,并记录所有患者随访并与初始降钙素水平关联。
主要发现
- 76例(50.1%)诊断为甲状腺髓样癌,其中21/76例(27.6%)有淋巴结转移,4例(5.3%)有远处转移。
- 使用预设cutoff值,患者可有效分为高于cutoff值组(甲状腺髓样癌确诊率100%)和低于cutoff值组(灰区,C细胞增生与甲状腺髓样癌显著重叠,均分类为pT1a;男性19/58[37.5%],女性7/41[17.1%])。
- 诊断甲状腺髓样癌的AUC在男性为基础降钙素0.894 vs 钙刺激后降钙素0.849,女性为基础降钙素0.935 vs 钙刺激后降钙素0.868。
- 诊断侧颈淋巴结转移的AUC在男性为基础降钙素0.925 vs 钙刺激后降钙素0.810,女性为基础降钙素0.797 vs 钙刺激后降钙素0.674。
- 女性cutoff值>85 pg/mL、男性>100 pg/mL时诊断侧颈淋巴结转移的敏感性为100%,低于这些cutoff值的患者无持续或复发病病(中位随访46[±27]个月)。
关键数值与推荐
- 男性基础降钙素>43和>100 pg/mL、女性>23和>85 pg/mL对患者咨询和手术范围规划有参考价值。
- 女性基础降钙素>85 pg/mL、男性>100 pg/mL预测侧颈淋巴结转移的敏感性为100%。
临床怎么用
- 预设的性别特异性基础降钙素cutoff值有助于甲状腺髓样癌的早期检测和侧颈淋巴结转移的预测。
- 钙刺激后降钙素未改善术前诊断,联合检测未提高诊断准确性。
- 男性基础降钙素>43和>100 pg/mL、女性>23和>85 pg/mL可用于患者咨询和手术范围规划。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Measurements of both basal (b) calcitonin (CT) and calcium (Ca)-stimulated CT (Ca-sCT) levels are performed to identify medullary thyroid cancer (MTC) at an early stage when used as part of the diagnostic workup of thyroid nodules (CT screening). Novel immunochemiluminometric assays, which are highly sensitive and specific for monomeric CT and avoid cross-reactivity, have been introduced over the past decade. No prospectively generated data have so far become available to answer the frequently raised question as to whether Ca-sCT in contrast to bCT alone is helpful and, therefore, still indicated for the early detection of MTC. Methods: Ca-stimulation tests were performed in 149 consecutive patients with thyroid nodules and elevated bCT. Regardless of Ca-sCT levels, all patients had an operation applying a uniform surgical protocol, including thyroidectomy and systematic lymph node dissection. Recently published sex-specific cutoff levels for the differentiation of MTC and other C-cell pathologies (C-cell hyperplasia [CCH]) were used to compare the diagnostic performance of bCT or Ca-sCT alone and in combination using receiver-operating characteristic (ROC) analysis. In addition, CT cutoff levels to predict lateral lymph node metastasis were evaluated for bCT compared with Ca-sCT. Follow-up for all patients was documented and correlated with initial CT levels. Results: MTC was identified in 76 (50.1%) patients, in 21/76 (27.6%) with lymph node and in 4 (5.3%) with distant metastasis. Using predefined cutoff levels, patients could effectively be subdivided into a group above the cutoff level with definitive diagnosis of MTC (100%) and below (gray zone) with a significant overlap of CCH and MTC (all classified as pT1a; males: 19/58 [37.5%], females: 7/41 [17.1%]). The areas under the ROC curve (AUC) were excellent for the diagnosis of MTC in all tests. Determination of bCT proved to be superior for both diagnosing MTC in males (AUC for bCT: 0.894; AUC for Ca-sCT: 0.849) and females (bCT: 0.935; Ca-sCT: 0.868) and also for diagnosing lymph node metastasis in the lateral compartment (males: bCT: 0.925; Ca-sCT: 0.810; females: bCT: 0.797; Ca-sCT: 0.674). Combining both tests did not improve diagnostic accuracy. Using a cutoff level of >85 pg/mL for females and >100 pg/mL for males, the sensitivity for diagnosing lateral neck lymph node metastasis was 100%. Below these cutoff levels, no patient showed persistent or recurrent disease (median follow-up: 46 [ ± 27] months). Conclusions: Predefined sex-specific bCT cutoff levels are helpful for the early detection of MTC and for predicting lateral neck lymph node metastasis. Ca-sCT did not improve preoperative diagnostics. bCT levels >43 and >100 pg/mL for males and of >23 and >85 pg/mL for females are relevant for advising patients and planning the extent of surgery.
引用
- Niederle MB, Scheuba C, Riss P, et al. Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays? Thyroid. 2020. PMID: 32056502. doi:10.1089/thy.2019.0785
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。